Influence of dietary components on the gastrointestinal metabolism and transport of drugs

Therapeutic Drug Monitoring

Volumn 22, Issue 1, 2000, Pages 131-136

  Evans, Allan M ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Flavonoids; Intestinal metabolism; Intestinal transport; Isoflavonoids; P glycoprotein

Indexed keywords

AURANTIIN; DAIDZEIN; FLAVONOID; FUROCOUMARIN; GENISTEIN; GLYCOPROTEIN P; ISOFLAVONE DERIVATIVE;

ANION TRANSPORT; ARTICLE; CHEMICAL STRUCTURE; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; FOOD DRUG INTERACTION; FOOD INTAKE; INTESTINE ABSORPTION; LIVER BLOOD FLOW; NONHUMAN; NUTRITIONAL STATUS; PH; PRIORITY JOURNAL; STOMACH EMPTYING;

ANIMALS; BEVERAGES; BIOLOGICAL TRANSPORT, ACTIVE; CITRUS; DIET; DIGESTIVE SYSTEM; FLAVONOIDS; FOOD-DRUG INTERACTIONS; HUMANS; P-GLYCOPROTEIN; PHARMACEUTICAL PREPARATIONS;

EID: 0033973926     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200002000-00028     Document Type: Article

References (42)

1. Charman WN, Porter CJH, Mithani S, Dressman JB. Physioco-chemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 1997;86: 269-82.
2. Fleisher D, Li C, Zhou Y, Pao L-H, Karim A. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications. Clin Pharmacokinet 1999;36: 233-54.
3. Ioannides C. Effect of diet and nutrition on the expression of cytochromes P450. Xenobiotica 1999;29:109-54.
4. Anderson KE. Influences of diet and nutrition on clinical pharmacokinetics. Clin Pharmacokinet 1988;14:325-46.
5. Walter-Sack I, Klotz U. Influence of diet and nutritional status on drug metabolism. Clin Pharmacokinet 1996;31:47-64.
6. Bailey DG, Spence JD, Munoz C, Arnold JMO. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991;337: 268-9.
7. Ameer B, Weintraub RA. Drug interactions with grapefruit juice. Clin Pharmacokinet 1997;33:103-21.
8. Bailey DG, Arnold JMO, Spence JD. Grapefruit juice-drug interactions. Br J Clin Pharmacol 1998;46:101-10.
9. Fuhr U. Drug interactions with grapefruit juice. Extent, probable mechanisms and clinical relevance. Drug Saf 1998;18:251-72.
10. Lilja JJ, Kivistö KT, Neuvonen PJ. Grapefruit juice-simvastatin interaction: Effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin Pharmacol Ther 1998;64:477-83.
11. Kantola T, Kivistö KT, Neuvonen PJ. Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid. Clin Pharmacol Ther 1998;63:397-402.
12. Lilja JJ, Kivistö KT, Backman JT, Lamberg TS, Neuvonen PJ. Grapefruit juice substantially increases plasma concentrations of buspirone. Clin Pharmacol Ther 1998;64:655-60.
13. Paine MF, Shen DD, Kunze KL et al. First-pass metabolism of midazolam by the human intestine. Clin Pharmacol Ther 1996;60: 12-24.
14. Kupferschmidt HHT, Ha HR, Ziegler WH, Meier PJ, Krähenbühl S. Interaction between grapefruit juice and midazolam in humans. Clin Pharmacol Ther 1995;58:20-8.
15. Lundahl J, Regärdh CG, Edgar B, Johnsson G. Effects of grapefruit juice ingestion - pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Eur J Clin Pharmacol 1997;52:139-45.
16. Ducharme MP, Warbasse LH, Edwards DJ. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther 1995;57:485-91.
17. Lown KS, Bailey DG, Fontana RI et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 1997;99:2545-53.
18. Lundahl J, Regärdh CG, Edgar B, Johnsson G. Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. Eur J Clin Pharmacol 1995;49:61-7.
19. Miniscalo A, Lundahl J, Regärdh CG, Edgar B, Ericsson UG. Inhibition of dihydropyridine metabolism in rt and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther 1992;261:1195-9.
20. Bailey DG, Arnold JMO, Munoz C, Spence JD. Grapefruit juice-felodipine interaction: mechanism, predictability, and effect of naringin. Clin Pharmacol Ther 1993;53:637-42.
21. Bailey DG, Arnold MO, Strong HA, Munoz C, Spence JD. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin Pharmacol Ther 1993;54:589-94.
22. Edwards DJ, Bellevue III FH, Woster PM. Identification of 6′,7′-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metab Dispos 1996;24:1287-90.
23. Schmiedlin-Ren P, Edwards DJ, Fitzsimmons ME, et al. Mechanism of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos 1997;25:1228-33.
24. He K, Iyer KR, Hayes RN, Sinz MW, Woolf PF, Hollenberg PF. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem Res Toxicol 1998;11:252-9.
25. Edwards DJ, Fitzsimmons ME, Scheutz EG et al. 6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther 1999;65:237-44.
26. Bailey DG, Kreeft JH, Munoz C, Freeman DJ, Bend JR. Grapefruit juice-felodipine interaction: effect of naringin and 6′,7′-dihydroxybergamottin in humans. Clin Pharmacol Ther 1998;64:248-56.
27. Soldner A, Christians U, Susanto M, Wacher VJ, Silverman JA, Benet LZ. Grapefruit juice activates P-glycoprotein-mediated drug transport. Pharm Res 1999;16:478-84.
28. Takanaga H, Ohnishi A, Matsuo H, Sawada Y. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in Caco-2 cells. Biol Pharm Bull 1998;21:1062-6.
29. Hunter J, Hirst BH. Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption. Adv Drug Deliv Rev 1997;25:129-57.
30. Van Asperen J, Van Tellingen O, Beijnen JH. The pharmacological role of P-glycoprotein in the intestinal epithelium. Pharmacol Res 1998;37:429-35.
31. Wacher VJ, Silverman JA, Zhang Y, Benet LZ. Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. J Pharm Sci 1998;87:1322-30.
32. Arimori K, Nakano M. Drug exsorption from blood into the gastrointestinal tract. Pharmac Res 1998;15;371-6.
33. Benton RE, Honig PK, Zamani K, Cantilena LR, Woosley RL. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarisation on the electrocardiogram. Clin Pharmacol Ther 1996;59:383-8.
34. Honig PK, Wortham DC, Lazarev A, Cantilena LR. Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine. J Clin Pharmacol 1996;36:345-51.
35. Rau SE, Bend JR, Arnold MO et al. Grapefruit juice-terfenadine single-dose interaction: magnitude, mechanism, and relevance. Clin Pharmacol Ther 1997;61:401-9.
36. Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 1999;27: 866-71.
37. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences. JAMA 1993;269:1513-8.
38. Castro AF, Altenberg GA. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein. Biochem Pharmacol 1997;53:89-93.
39. Eaton EA, Walle UK, Lewis AJ, Hudson T, Wilson AA, Walle T. Flavonoids, potent inhibitors of the human P-form phenolsulfo-transferase. Potential role in drug metabolism and chemoprevention. Drug Metab Dispos 1996;24:232-7.
40. Jäger W, Zernbsch B, Wolschann P et al. Metabolism of the anticancer drug flavopiridol, a new inhibitor of cyclin dependent kinases, in rat liver. Life Sci 1998;62:1861-73.
41. Helsby NA, Chipman JK, Gescher A, Kerr D. Inhibition of mouse and human CYP 1A-and 2E1-dependent substrate metabolism by the isoflavonoids genistein and equol. Food Chem Toxicol 1998; 36:375-82.
42. Walle UK, French KL, Walgren RA, Walle T. Transport of genistein-7-glucoside by human intestinal Caco-2 cells: Potential role for MRP2. Res Commun Mol Pathol Pharmacol 1999;103:45-56.